Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Tilray Brands

Multiple cannabis stocks to buy should climb higher thanks to Washington's efforts to help the sector. So far, the federal government looks poised to undertake two initiatives that should greatly boost marijuana companies in the long term.

Cashing In on Cannabis: 3 Stocks Primed to Surge on Federal Reforms

Coinbase

Super Micro Computer

No risk, no reward, as the saying goes. While markets generally move in fits and starts, there are some stocks that prove to be multibaggers.

3 Stocks With the Potential to Make You an Overnight Millionaire

Beyond Meat

Nano Dimension

Chair of the Federal Reserve, Jerome Powell, has spoken, and Wall Street won't like it. The Fed has decided to hold off on cutting interest rates, citing discouraging developments in the fight against inflation.

Stock Market Crash Warning: Don't Get Caught Holding These 3 Nasdaq Stocks

Cronos Group

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF 

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling

The latest trading day saw Canopy Growth Corporation (CGC) settling at $10.24, representing a -0.97% change from its previous close.

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors

C$27.5 Millon of Debt Extended from 2025 to 2029 Providing Additional Balance Sheet Flexibility SMITHS FALLS, ON , May 3, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which Canopy Growth is expected to receive gross proceeds of approximately US$50 million and exchange approximately C$27.5 million of existing debt maturing in September 2025 for a new senior unsecured convertible debenture of the Company (the "Convertible Debenture") maturing five years from the date of issuance thereof (such issuance date being, the "Closing Date"). Pursuant to the terms of the Agreement, on the Closing Date, the Investor will acquire a Convertible Debenture in an aggregate principal amount equal to C$96,358,375 and the Company will issue to the Investor an additional 3,350,430 common share purchase warrants of the Company (each, a "Warrant").

Canopy Growth Announces Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds

Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, several leading cannabis stocks, like Tilray NASDAQ: TLRY, Aurora Cannabis NASDAQ: ACB, and Canopy Growth NASDAQ: CGC experienced notable upticks in volume and price, posting impressive double-digit intraday gains before pulling back on Wednesday.

Cannabis Stocks: Game-Changing Catalyst for the Sector?

Flora Growth Corp

For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.

Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks

The DEA recommended loosening regulations on marijuana yesterday. As a Schedule III drug, marijuana would still be regulated and some costs would rise for cannabis companies -- but others would fall.

Why Canopy Growth, Tilray, and Cronos Group Stocks Just Cratered

Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis from a Schedule I drug to a Schedule III drug.

Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally

Following a major breakthrough, cannabis operators such as Canopy Growth (NASDAQ: CGC ) saw their shares rise dramatically yesterday. As InvestorPlace's Shrey Dua reported, President Joe Biden's administration is moving to reschedule marijuana as a Schedule III substance.

Trade of the Day: Buy Canopy Growth (CGC) Stock Call Options on Rescheduling News

Canopy Growth Corp. and Tilray Brands Inc. stocks made more modest moves on Wednesday after a huge rally in the previous session on plans by the Biden administration to reclassify pot as less dangerous under federal law.

Cannabis stocks settle down after rally on plans to reclassify pot as less dangerous

GrowGeneration Corp

Leafly Holdings

OrganiGram Holdings Inc.

Constellation Brands

Though there has never been a shortage of enthusiasm and interest in cannabis stocks, many of them have failed to take off, with some even dropping more than 90% from their initial public offering (IPO) price and turning into penny stocks.

The next pot of gold? Marijuana stocks surge higher on promise of reclassification

SNDL Inc.

Cannabis stocks have gone parabolic. Tilray Brands (TLRY) stock jumped by over 39% on Tuesday while Canopy Growth (CGC) soared by over 78%.

Here's the risk for buying TLRY, CGC, MSOS, and SNDL stocks

WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple effects across the country.

U.S. poised to ease restrictions on marijuana in historic shift, though it'll remain controlled substance

The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.

US plans to reclassify cannabis as less dangerous drug

American Homes 4 Rent

Cannabis company stocks skyrocketed Tuesday following multiple reports marijuana will be reclassified to a less dangerous drug schedule, which could broaden the substance's medical usage and cut down regulations tied to it.

Cannabis Stocks Spike Following Reports Marijuana Will Be Reclassified As Less Dangerous Drug

The DEA officially agreed to recommend rescheduling cannabis from a Class I to a Class III drug. While it doesn't legalize cannabis, the measure has the potential to be hugely impactful to U.S. multi-state operators.

Why Cannabis Companies Tilray, Canopy Growth, Cronos, and SNDL Got Really High on Tuesday

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug

Cannabis stocks surged on Tuesday afternoon following multiple media reports that the US Drug Enforcement Administration will approve the reclassification of marijuana as a lower-risk drug. The news was first reported by the Associated Press, which cited five people familiar with the matter.

Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Cambria Cannabis ETF

Roundhill Cannabis ETF

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

Mario Naric On Canada's Shakeout Phase

Curaleaf Holdings, Inc.

A January Pew Research survey indicates that 88% of U.S. adults support the legalization of cannabis for medicinal use. Further, 57% adults opine that the legalization should be for recreational use as well.

3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential Election

The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press reported on Tuesday, citing five people familiar with the matter.

US drug enforcers to ease restrictions on cannabis, AP reports

Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled substance. For more than 50 years, cannabis has been a Schedule I substance under federal law, in the same bucket as heroin and fentanyl.

Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA

Canopy Growth can move ahead with its plans to acquire U.S.-based cannabis companies via Canopy USA. The company, however, won't be able to consolidate the results.

Canopy Growth Obtains Shareholder Approval to Move Ahead With Canopy USA: Here's What It Means for Investors

News for Canopy Growth Stock (CGC)